Florida Medicaid In The Spotlight: GSK Error Program Is Latest Experiment
Executive Summary
GlaxoSmithKline is expanding its formulary position in Florida's Medicaid program by implementing a medication error reduction program in lieu of supplemental rebates
You may also be interested in...
Florida Gets 36% Raise From Pfizer Under New Disease Management Contract
Pfizer's contract extension with Florida provides a 36% increase in savings from disease management programs over the previous agreement
Florida Gets 36% Raise From Pfizer Under New Disease Management Contract
Pfizer's contract extension with Florida provides a 36% increase in savings from disease management programs over the previous agreement
Florida Disease Management Report: Programs Save 11%; Rebates Save More
Industry-sponsored disease management services have saved the Florida Medicaid program approximately 11%, according to an analysis prepared for the state legislature